At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Lidoderm 5 % Topical Patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lidocaine Patch for Adjunct Analgesia for Postoperative Cesarean Birth Patients
In Brief
A Phase 4 clinical trial evaluating Lidoderm 5 % Topical Patch and Sham Topical Patch for Pain, Postoperative. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartMar 2018
First PostedApr 2018
Primary CompletionMar 2019
TodayJul 2026
First PostedApr 18, 2018
Enrollment StartMar 13, 2018
Primary CompletionMar 1, 2019
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 8.2 years ago
Interventions
Lidoderm 5 % Topical Patchdrug
Lidocaine patch after cesarean section delivery.
Sham Topical Patchother
Sham patch after cesarean section delivery.